Brain Chemistry Labs
Not-for-profit research institute in Jackson Hole, Wyoming focused on discovering causes, diagnostics, and treatments for neurodegenerative diseases (Alzheimer’s, ALS, Parkinson’s). Operates a laboratory and a virtual, consortium-style research model that coordinates external experts to advance preclinical and translational research on environmental neurotoxins, biomarkers, and natural-product therapeutics.
Industries
Nr. of Employees
small (1-50)
Brain Chemistry Labs
Jackson, Wyoming, United States, North America
Patents
Products
Blood-based ALS diagnostic test (preclinical)
A blood diagnostic assay built on a miRNA fingerprint intended to identify ALS; reported preclinical study performance metrics indicate high accuracy in initial studies.
Blood-based ALS diagnostic test (preclinical)
A blood diagnostic assay built on a miRNA fingerprint intended to identify ALS; reported preclinical study performance metrics indicate high accuracy in initial studies.
Services
Collaborative execution of preclinical studies, biomarker discovery, diagnostic assay development, and environmental sample analysis using a distributed consortium model.
Collaborative execution of preclinical studies, biomarker discovery, diagnostic assay development, and environmental sample analysis using a distributed consortium model.
Expertise Areas
- Neurodegenerative disease research (Alzheimer’s, ALS, Parkinson’s)
- Biomarker discovery and diagnostic assay development
- Preclinical in vivo modeling and translational research
- Environmental toxicology and exposure assessment (cyanotoxins/BMAA)
Key Technologies
- Blood-based diagnostic assays
- miRNA profiling / biomarker fingerprinting
- In vivo primate and animal models
- Neuropathology and brain tissue analysis
News & Updates
Research linking dolphin neuropathology to cyanobacterial toxins and reporting Alzheimer’s-like brain changes in stranded dolphins.
Coverage of a blood-based diagnostic approach for ALS using a miRNA fingerprint with reported ~98% accuracy in preclinical studies.
Reports on preclinical findings that a plant-derived violet compound enhances chemotherapy effectiveness against glioblastoma in experimental studies.
Research linking dolphin neuropathology to cyanobacterial toxins and reporting Alzheimer’s-like brain changes in stranded dolphins.
Coverage of a blood-based diagnostic approach for ALS using a miRNA fingerprint with reported ~98% accuracy in preclinical studies.
Reports on preclinical findings that a plant-derived violet compound enhances chemotherapy effectiveness against glioblastoma in experimental studies.